CIK: 1588984 - Address: C/O Ngm Biopharmaceuticals, Inc., 333 Oyster Point Boulevard, South San Francisco, CA 94080
21 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret113-2-2-15-43-44-47-26
S%wins100336710010010083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/16/21 17:52
6/14/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-31331.630-10-4242D
5/20/21 20:30
5/18/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-9427.490-3-1252D
3/17/21 21:24
3/15/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-77942.900-18-7228D
3/3/21 18:57
3/2/21
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-12942.980-3-1222D
11/20/20 21:13
11/18/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-14046.750-3-1225D
9/14/20 18:45
9/10/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-2133.870-10228D
8/20/20 17:53
8/19/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-60832.100-19-8227D
7/20/20 18:35
7/17/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-39833.160-12-5246D
5/22/20 18:02
5/20/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-8816.700-5-3199D
3/16/20 21:39
3/16/20
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-12611.790-11-5204D
8/21/19 18:36
8/19/19
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-62125.380-24-17123D
5/22/19 19:59
5/20/19
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-17218.030-10-6147D
3/1/19 19:24
2/27/19
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-8020.000-4-2157D
1/18/19 17:34
1/16/19
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-5814.490-4-2161D
5/16/18 21:11
5/15/18
NVTAInvitae CorpDEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS-366.960-5-1140D
7/28/15 18:30
7/24/15
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOM.d66.04110D-18512262250-12-29-38-41-54
7/28/15 18:30
7/24/15
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS.d-1212.471-1-1000D-18512262250-12-29-38-41-54
6/30/15 19:29
6/26/15
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOM.d66.04210D-3620574-1-2-4-5-121-51-36-55
6/30/15 19:29
6/26/15
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS.d-1212.082-1-1000D-3620574-1-2-4-5-121-51-36-55
6/23/14 21:10
6/20/14
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOM.d86.04110D17-92511111204-16-40-56-32
6/23/14 21:10
6/20/14
VCYTVeracyte, Inc.DEHealthHealthMedical LaboratoriesGuyer Shelly DCAOCFOS.d-2016.041-1-1000D17-92511111204-16-40-56-32

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact